Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial)
<p><strong>Background</strong><br/> Pre-eclampsia is a pregnancy disorder, characterised by hypertension and multisystem complications in the mother. The adverse outcomes of pre-eclampsia include severe hypertension, stroke, renal and hepatic injury, haemorrhage, fetal growth...
Main Authors: | Chappell, L, Green, M, Marlow, N, Sandall, J, Hunter, R, Robson, S, Bowler, U, Chiocchia, V, Hardy, P, Juszczak, E, Linsell, L, Placzek, A, Brocklehurst, P, Shennan, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2019
|
Similar Items
-
Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial)
by: Lucy C. Chappell, et al.
Published: (2019-01-01) -
Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): A randomized controlled trial
by: Chappell, LC, et al.
Published: (2020) -
Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
by: Chappell, L, et al.
Published: (2019) -
Two-year follow-up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
by: Beardmore-Gray, A, et al.
Published: (2022) -
Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT
by: Chappell, LC, et al.
Published: (2022)